pharmaphorum7y
FDA clears finger-prick free insulin pump-CGM combo
Tandem Diabetes’ t:slim X2 Insulin Pump has received FDA approval for use alongside Dexcom’s G5 Mobile continuous glucose monitoring (CGM) technology. The approval is part of a rapid evolution ...
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...
Dexcom’s G7 Hospital CGM Poised for Market Breakthrough with NTAP and FDA Approvals
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price ...
Here’s Why DexCom (DXCM) Declined In Q3
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...
pharmaphorum7y
Fitbit and Dexcom to bring diabetes data to Ionic smartwatch
Part of a broader initiative between the two companies to “develop and market products to help people better manage their diabetes”, Dexcom G5 Mobile users will now be able to sync their CGM ...